ALPS Medical Breakthroughs ETF
SBIO
#2384
ETF rank
โ‚ฌ0.11 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
42,35ย โ‚ฌ
Share price
-0.63%
Change (1 day)
37.20%
Change (1 year)

Expense ratio and fees for ALPS Medical Breakthroughs ETF (SBIO)

Gross Expense Ratio

Gross Expense Ratio as of February 2026: 0.5%

Net Expense Ratio

Net Expense Ratio as of February 2026: 0.5%